Jonathan David Schwartz is of ROCKET PHARMACEUTICALS, INC.. Currently has a direct ownership of 94,546 shares of RCKT, which is worth approximately $1.89 Million. The most recent transaction as insider was on Feb 17, 2023, when has been sold 3,557 shares (Common Stock) at a price of $19.06 per share, resulting in proceeds of $67,796. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 94.5K
0% 3M change
0% 12M change
Total Value Held $1.89 Million

Jonathan David Schwartz Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 17 2023
SELL
Open market or private sale
$67,796 $19.06 p/Share
3,557 Reduced 3.63%
94,546 Common Stock
Mar 30 2022
SELL
Open market or private sale
$731,250 $16.25 p/Share
45,000 Reduced 20.04%
179,529 Common Stock
Feb 01 2021
BUY
Exercise of conversion of derivative security
$325,567 $1.45 p/Share
224,529 Added 50.0%
224,529 Common Stock

Also insider at

TRHC
Tabula Rasa HealthCare, Inc. Healthcare
JDS

Jonathan David Schwartz

Cranbury, NJ

Track Institutional and Insider Activities on RCKT

Follow ROCKET PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RCKT shares.

Notify only if

Insider Trading

Get notified when an Rocket Pharmaceuticals, Inc. insider buys or sells RCKT shares.

Notify only if

News

Receive news related to ROCKET PHARMACEUTICALS, INC.

Track Activities on RCKT